MTOR and fatty liver disease: CAPE improved glucose uptake and utilization-related gene expression in the hepatopancreas and muscle, alleviated hepatic steatosis, and promoted mammalian target of rapamycin (mtor) gene expression in muscle for grass carp on the HCD (P = 0.034).